Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $2.6 million.

  • AtriCure's Capital Expenditures fell 2779.93% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 1221.43%. This contributed to the annual value of $11.5 million for FY2024, which is 449.24% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Capital Expenditures is $2.6 million, which was down 2779.93% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Capital Expenditures registered a high of $5.1 million during Q3 2022, and its lowest value of $1.3 million during Q1 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $2.8 million (2024), whereas its average is $3.0 million.
  • In the last 5 years, AtriCure's Capital Expenditures skyrocketed by 27886.69% in 2021 and then tumbled by 3320.55% in 2023.
  • AtriCure's Capital Expenditures (Quarter) stood at $2.7 million in 2021, then surged by 53.91% to $4.2 million in 2022, then crashed by 33.21% to $2.8 million in 2023, then dropped by 3.34% to $2.7 million in 2024, then decreased by 3.27% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.7 million for Q2 2025, and $2.2 million during Q1 2025.